Pathogen Education Facts About Ebola Virus · Ebola, previously known as Ebola hemorrhagic fever,...
2
Ebola, previously known as Ebola hemorrhagic fever, is a severe and dangerous disease What Is Ebola? Pathogen Education Facts About Ebola Virus Symptoms and Treatment Ebola is only contagious if the person is experiencing active symptoms. Typical symptoms include: fever, severe headache, muscle pain, diarrhea, vomiting, abdominal pain, and unexplained hemorrhaging. Symptoms may appear anywhere from 2 to 21 days after exposure to Ebola, but the average is 8 to 10 days. CDC has issued guidance for healthcare professionals to safely manage patients with suspected or confirmed Ebola Virus Disease in the United States. ii How Does It Spread? Ebola is transmitted through direct contact with the blood or body fluids. Ebola is not transmitted through the air or water. Generally, Ebola is not a foodborne illness. Ebola is often spread through families and friends because they come in close contact with infectious secretions when caring for ill persons. Healthcare workers providing care for Ebola patients are also at risk for getting sick. During outbreaks of Ebola, the disease can spread quickly within healthcare settings (such as a clinic or hospital) if hospital staff and other workers are not wearing protective equipment, such as masks, gowns, and gloves. CDC recommends monitoring exposed people for symptoms for a complete 21 days. What Should Be Done to Help Reduce the Risk? Healthcare workers are advised to use isolation and infection control procedures including standard, contact, and droplet precautions. Specific recommendations include isolating the patient, wearing appropriate PPE, restricting visitors, and avoiding aerosol-generating procedures. Healthcare workers who may be exposed to people with Ebola should follow these steps: Wear protective clothing, including masks, gloves, gowns, and eye protection. Practice proper infection control and sterilization measures. Isolate patients with Ebola from other patients. Notify health officials if you have had direct contact with blood or body fluids, such as but not limited to, feces, saliva, urine, vomit, and semen of a person who is sick with Ebola. Healthcare workers are advised to follow CDC’s infection control recommendations for healthcare providers to use isolation and infection control procedures including standard, contact, and droplet precautions to safely manage hospitalized patients with known or suspected Ebola hemorrhagic fever. www.cdc.gov/vhf/ebola/hcp/ infection-prevention-and-control- recommendations.html In August 2014, the CDC released Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals. For updated information on Ebola virus, please visit the CDC’s Ebola Hemorrhagic Fever website , www.cdc.gov/vhf/ebola/ i iii Centers for Disease Control and Prevention. “Ebola (Ebola Virus Disease).” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/index.html i DISINFECTING CLEANING Centers for Disease Control and Prevention. “Safe Management of Patients with Ebola Virus Disease (EVD) in U.S. Hospitals.” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/hcp/patient-management-us-hospitals.html ii Centers for Disease Control and Prevention. “Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals.” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html iii No FDA-approved vaccine or medicine (e.g., antiviral drug) is available for Ebola. Ebola virus causes viral hemor- rhagic fever disease (also called Ebola Hemorrhagic Fever or Ebola Virus Disease), a severe, often fatal disease in humans. Ebola virus is a member of the Filoviridae family of viruses, which are lipid-enveloped RNA viruses. Ebola virus was first identified in 1976 in Africa. To date, 5 different subtypes of Ebola viruses have been identified. CDC has been working with medical and public health professionals across the United States and abroad to prepare and respond to any potential or confirmed Ebola cases.
Transcript of Pathogen Education Facts About Ebola Virus · Ebola, previously known as Ebola hemorrhagic fever,...
Ebola, previously known as Ebola hemorrhagic fever, is a severe and dangerous disease
What Is Ebola?
Pathogen Education
Facts About Ebola Virus
Symptoms and TreatmentEbola is only contagious if theperson is experiencing activesymptoms. Typical symptomsinclude: fever, severe headache,muscle pain, diarrhea, vomiting,abdominal pain, and unexplainedhemorrhaging.
Symptoms may appear anywherefrom 2 to 21 days after exposure to Ebola, but the average is 8 to10 days.
CDC has issued guidance forhealthcare professionals to safelymanage patients with suspectedor confirmed Ebola Virus Diseasein the United States.ii
How Does It Spread?Ebola is transmitted through directcontact with the blood or body fluids. Ebola is not transmitted through theair or water. Generally, Ebola is nota foodborne illness.
Ebola is often spread through familiesand friends because they come in closecontact with infectious secretions when caring for ill persons. Healthcare workersproviding care for Ebola patients are alsoat risk for getting sick.
During outbreaks of Ebola, the diseasecan spread quickly within healthcaresettings (such as a clinic or hospital)if hospital staff and other workers arenot wearing protective equipment,such as masks, gowns, and gloves.
CDC recommends monitoring exposedpeople for symptoms for a complete 21 days.
What Should Be Done to HelpReduce the Risk?
Healthcare workers are advised to useisolation and infection control proceduresincluding standard, contact, and dropletprecautions. Specific recommendationsinclude isolating the patient, wearing appropriate PPE, restricting visitors, andavoiding aerosol-generating procedures.
Healthcare workers who may be exposedto people with Ebola should follow thesesteps:
Wear protective clothing, including masks, gloves, gowns, and eye protection.
Practice proper infection control andsterilization measures.
Isolate patients with Ebola from otherpatients.
Notify health officials if you have had direct contact with blood or body fluids,such as but not limited to, feces, saliva,urine, vomit, and semen of a person whois sick with Ebola.
Healthcare workers are advised to follow CDC’s infection control recommendationsfor healthcare providers to use isolation and infection control procedures includingstandard, contact, and droplet precautionsto safely manage hospitalized patients with known or suspected Ebola hemorrhagic fever.
www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html
In August 2014, the CDC releasedInfection Prevention and ControlRecommendations for HospitalizedPatients with Known or SuspectedEbola Hemorrhagic Fever in U.S.Hospitals.
For updated information on Ebola virus, please visit the CDC’sEbola Hemorrhagic Fever website , www.cdc.gov/vhf/ebola/i
iii
Centers for Disease Control and Prevention. “Ebola (Ebola Virus Disease).” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/index.html
i
DISINFECTING CLEANING
Centers for Disease Control and Prevention. “Safe Management of Patients with Ebola Virus Disease (EVD) in U.S. Hospitals.” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/hcp/patient-management-us-hospitals.html
ii
Centers for Disease Control and Prevention. “Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals.” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html
iii
No FDA-approved vaccine or medicine (e.g., antiviral drug) isavailable for Ebola.
Ebola virus causes viral hemor-rhagic fever disease (also calledEbola Hemorrhagic Fever or EbolaVirus Disease), a severe, oftenfatal disease in humans. Ebola virus is a member of the Filoviridae family of viruses,which are lipid-envelopedRNA viruses.
Ebola virus was first identified in 1976 in Africa. To date, 5 differentsubtypes of Ebola viruses have beenidentified.
CDC has been working with medicaland public health professionalsacross the United States and abroad to prepare and respondto any potential or confirmed Ebola cases.
www.cloroxprofessional.comNI-26965(R2)
Quat-Based
†
Clorox EPA-Registered Hospital Disinfectants to Disinfect Hard Non-Porous Surfaces
Clorox Commercial Solutions ®
Clorox Germicidal Bleach 1
Case UPC: 30966 3/121 oz
Case UPC: 31009 8/64 oz
Bleach-Based
PRODUCT INFORMATION
Currently, the Ebola virus is not available for efficacy testing in the United States. There are no surface disinfectant products with an EPA-registered claim to kill the Ebola virus. However, the CDC recommends the use of EPA-registered hospital disinfectants with label claimsfor non-enveloped viruses to disinfect environmental surfaces in hospitals housing patients with known or suspected Ebola virus infection.
EPA Reg. No. 5813-100-67619
®
Clorox Commercial Solutions®
Clorox Disinfecting Wipes
Case UPC: 15948 6/75 ct Lemon
Case UPC: 15949 6/75 ct Fresh
PRODUCT INFORMATION
EPA Reg. No. 67619-9
®
Clorox Commercial Solutions®
Clorox Toilet Bowl Cleaner with Bleach
Case UPC: 00031 12/24 oz Fresh Scent
PRODUCT INFORMATION
EPA Reg. No. 67619-16
®
Clorox Commercial Solutions®
Clorox Clean-Up DisinfectantCleaner with Bleach
Case UPC: 35417 9/32 oz Spray
Case UPC: 35420 4/128 oz Dilutable
PRODUCT INFORMATION
EPA Reg. No. 67619-17
® ®
1
Clorox Commercial Solutions®
Clorox Disinfecting Spray
Case UPC: 38504 12/19 oz
PRODUCT INFORMATION
EPA Reg. No. 67619-21
®
Clorox Commercial Solutions®
Clorox Pro QuaternaryAll-Purpose Disinfecting Cleaner
Case UPC: 30423 2/128 oz
PRODUCT INFORMATION
EPA Reg. No. 1839-166-67619
®
1
Clorox Broad SpectrumQuaternary Disinfectant Cleaner
Case UPC: 30649 9/32 oz Spray
Case UPC: 30651 4/128 oz Refill
PRODUCT INFORMATION
EPA Reg. No. 67619-20
®
Case UPC: 68967 8/22 oz Spray
Case UPC: 68970 6/32 oz Spray
Case UPC: 68832 6/32 oz Pull-Top
Case UPC: 68973 6/64 oz Refill
Case UPC: 68978 4/128 oz Refill
PRODUCT INFORMATION
EPA Reg. No. 56392-7
Clorox Healthcare
Bleach Germicidal Cleaner®
6.75”x9” Multipurpose Wipes
6”x5” Clinical Wipes
12”x12” Terminal Wipes
12”x12” Terminal Wipes
PRODUCT INFORMATION
EPA Reg. No. 67619-12
Clorox Healthcare
Bleach Germicidal Wipes®
Case UPC: 35309 6/70 ct
Case UPC: 30577 6/150 ct
Case UPC: 30358 2/110 ct Bucket
Case UPC: 30359 2/110 ct Refill
Hydrogen Peroxide Products
Bleach-Based
* Use as directed on hard, nonporous surfaces. Alcohol is also an active ingredient in Clorox Disinfecting Spray.
© 2014 Clorox Professional Products Company,
1221 Broadway, Oakland, CA 94612
Alcohol-BasedClorox Commercial Solutions®
Clorox 4 in One Disinfectant & Sanitizer
Case UPC: 31043 12/14 oz
PRODUCT INFORMATION
EPA Reg. No. 67619-29
®
Centers for Disease Control and Prevention. “Interim Guidance for Environmental InfectionControl in Hospitals for Ebola Virus.” Atlanta, CDC: Accessed 3 October 2014. Available from: www.cdc.gov/vhf/ebola/hcp/environmental-infection-control-in-hospitals.html
iv
Clorox Commercial Solutions®
Clorox Disinfecting Bathroom Cleaner
Case UPC: 16930 9/30 oz
PRODUCT INFORMATION
EPA Reg. No. 5813-40-67619
®
Case UPC: 30824 6/95 ct
Case UPC: 30825 6/155 ct
Case UPC: 30826 2/185 ct Bucket
Case UPC: 30825 2/185 ct Refill
PRODUCT INFORMATION
Wipes: EPA Reg. No. 67619-25
6.75”x9” Multipurpose Wipes
6.75x5.75” Clinical Wipes
12”x11” Terminal Wipe
12”x11” Terminal Wipe
Sprays: EPA Reg. No. 67619-24
Clorox Healthcare
Hydrogen Peroxide Disinfectant Sprays and Wipes
®
Case UPC: 30649 9/32 oz Spray
PRODUCT INFORMATIONCase UPC: 30651 4/128 oz Refill
Clorox Commercial Solutions®
Clorox Hydrogen PeroxideDisinfecting Spraysand Wipes
Case UPC: 30649 9/32 oz SprayPRODUCT INFORMATIONSprays: EPA Reg. No. 67619-24
®
Case UPC: 30651 4/128 oz Refill
Wipes: EPA Reg. No. 67619-25
Case UPC: 30830 6/110 ctPRODUCT INFORMATION
Case UPC: 30831 2/800 ct Refill
Clorox Healthcare®
Citrace HospitalDisinfectant &Deodorizer
Case UPC: 49100 12/14 oz
PRODUCT INFORMATION
EPA Reg. No. 67619-29
®
† ®
iv
